A phase II study of S-1 and cisplatin with concurrent thoracic radiotherapy followed by durvalumab for unresectable, locally advanced non-small-cell lung cancer in Japan (SAMURAI study)

BACKGROUND: Based on the results of the PACIFIC study, chemoradiotherapy followed by 1-year consolidation therapy with durvalumab was established as the standard of care for unresectable, locally advanced non-small-cell lung cancer (LA-NSCLC). However, some topics not foreseen in that design can be...

Descripción completa

Detalles Bibliográficos
Autores principales: Tanzawa, Shigeru, Ushijima, Sunao, Shibata, Kazuhiko, Shibayama, Takuo, Bessho, Akihiro, Kaira, Kyoichi, Misumi, Toshihiro, Shiraishi, Kenshiro, Matsutani, Noriyuki, Tanaka, Hisashi, Inaba, Megumi, Haruyama, Terunobu, Nakamura, Junya, Kishikawa, Takayuki, Nakashima, Masanao, Iwasa, Keiichi, Fujiwara, Keiichi, Kohyama, Tadashi, Kuyama, Shoichi, Miyazawa, Naoki, Nakamura, Tomomi, Miyawaki, Hiroshi, Ishida, Hiroo, Oda, Naohiro, Ishikawa, Nobuhisa, Morinaga, Ryotaro, Kusaka, Kei, Fujimoto, Nobukazu, Yokoyama, Toshihide, Gemba, Kenichi, Tsuda, Takeshi, Nakagawa, Hideyuki, Ono, Hirotaka, Shimizu, Tetsuo, Nakamura, Morio, Kusumoto, Sojiro, Hayashi, Ryuji, Shirasaki, Hiroki, Ochi, Nobuaki, Aoe, Keisuke, Kanaji, Nobuhiro, Kashiwabara, Kosuke, Inoue, Hiroshi, Seki, Nobuhiko
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2021
Materias:
Study Protocol
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7917867/
https://www.ncbi.nlm.nih.gov/pubmed/33717228
http://dx.doi.org/10.1177/1758835921998588

Ejemplares similares

Ejemplares similares